Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Aquestive Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 180
- +3 vs. Q4 2025
- Shares held
- 71.9M
- +5.49M (+8.3%) vs. Q4 2025
- Total value
- $298.6M
- −$130.3M (−30.4%) vs. Q4 2025
- New holders
- 48
- 57 more added
- Sold out
- 45
- 47 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −56,545−100.0% | Sold out |
| MONECO Advisors, LLC | 0 | $0 | 0.00% | −38,515−100.0% | Sold out |
| Arcataur Capital Management LLC | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −34,518−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −29,213−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −28,745−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −28,458−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −29,962−100.0% | Sold out |
| KLP Kapitalforvaltning AS | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −17,128−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −17,090−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −14,954−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −14,581−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −14,044−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −11,496−100.0% | Sold out |
| Modern Wealth Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −6,289−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −3,282−100.0% | Sold out |
| Hurley Capital, LLC | 0 | $0 | 0.00% | −1,569−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Westfuller Advisors, LLC | 0 | $0 | 0.00% | −769−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −553−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |